Damages Actions for Breach of the EC Antitrust Rules: The Commission's Green Paper

The pharmaceutical industry has a particular interest in the consultation launched via the Commission's Green Paper on damages actions for breach of the EC antitrust rules, says John Pheasant, partner and co-head of European Antitrust at international law firm Hogan & Hartson.

Download PDF Share Back To Listing
Loading data